Assurant- 5.25% NT REDEEM 15/01/2061 USD 25 EBIT

Assurant- 5.25% NT REDEEM 15/01/2061 USD 25 (AIZN) currently reports a EBIT of $1.3B as of March 2026. That compares with $560M in the prior-year period — up 134.1% year over year. That is below the Finance sector average of $300B. Use the charts on this page to explore Assurant- 5.25% NT REDEEM 15/01/2061 USD 25's EBIT history and peer comparisons.

Assurant- 5.25% NT REDEEM 15/01/2061 USD 25's EBIT increased from $560M to $1.3B — a 134.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Assurant- 5.25% NT REDEEM 15/01/2061 USD 25's EBIT of $1.3B is lower than the Finance sector average of $300B. That is roughly 99.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Assurant- 5.25% NT REDEEM 15/01/2061 USD 25 reported $1.3B in EBIT as of March 2026. That compares with $560M in the prior-year period — up 134.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $1.3B, then check the historical chart for trend and the peer comparison chart for relative positioning. The Finance average is $300B. From there, open related valuation or income-statement pages for Assurant- 5.25% NT REDEEM 15/01/2061 USD 25, and consider following AIZN for alerts when major investors trade the stock.